Eutylone is a topic that has generated great interest in recent years. Since its emergence, it has captured the attention of experts and fans alike, due to its relevance and reach in different areas. This phenomenon has sparked endless debates, theories and studies that seek to understand it in its entirety. Likewise, its impact on society and popular culture make it a topic of constant discussion today. In this article, we will explore the different facets and perspectives surrounding Eutylone, with the aim of offering a comprehensive and enriching vision of this phenomenon.
![]() | |
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII |
|
KEGG | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C13H17NO3 |
Molar mass | 235.283 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Eutylone (also known as β-keto-1,3-benzodioxolyl-N-ethylbutanamine, bk-EBDB, and N-ethylbutylone) is a stimulant and empathogenic drug of the phenethylamine, amphetamine, phenylisobutylamine, and cathinone families which was developed in the 1960s,[3][4] which is classified as a designer drug.[5] It was first reported to the EMCDDA in 2014 and became widespread internationally in 2019-2020 following bans on the related compound ephylone.[6][7][8][9] It is a synthetic cathinone.[9] In 2021, eutylone was the most common cathinone identified by the Drug Enforcement Administration in the United States.[10]
Sweden's public health agency suggested classifying eutylone as a hazardous substance, on September 25, 2019.[11]
In the United States Eutylone is considered a schedule 1 controlled substance as a positional isomer of Pentylone.[12][13]